Overview

Open, Randomized, Two Way Crossover Study Comparing the Effect of Esomeprazole Adminstered Orally and iv

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the effects of Nexium at a dose of 20mg administered orally compared to intravenously on the maximum acid output in subjects with symptoms of Gastroesophageal reflux disease (GERD).
Phase:
Phase 4
Details
Lead Sponsor:
AstraZeneca
Treatments:
Esomeprazole